A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...
AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...
Aaron Johnstone has resigned from his position as Queensland Renewable Energy Jobs Advocate. The position is to be abolished by the state government under its new energy roadmap. Heidi Sick is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback